Fundz
Real-time · AI · Cross-signal

Terumo Health Outcomes and Medis Medical Imaging just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Terumo Health Outcomes and Medis Medical Imaging, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Terumo and Medis Announce Strategic Partnership to Enhance Cardiovascular Care

Dec 10, 2024•over 1 year ago

Contract Type

partnership

North Rhine-WestphaliaBiotechnologyHealth CareMedical

Description

Terumo Health Outcomes and Medis Medical Imaging have formed a strategic partnership to enhance cardiovascular care by using innovative technologies to improve clinical outcomes and streamline the care pathway. The partnership will integrate ePRISM platform with QFR technology to provide comprehensive solutions for enhancing diagnostic accuracy and treatment planning.

Company Information

Company

Terumo Health Outcomes and Medis Medical Imaging

Location

North Rhine-Westphalia, Germany

About

Terumo Health Outcomes and Medis Medical Imaging announced a strategic partnership to enhance cardiovascular care in the U.S. by utilizing Terumo’s ePRISM proprietary clinical decision support platform with Medis’ quantitative flow ratio (QFR) technology.

Predictive Intelligence
Strategic

ML-powered predictions for Terumo Health Outcomes and Medis Medical Imaging's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months